S
Sarfroz
About Sarfroz
Data last updated:
Sarfroz is a Director at Reinvent Medical Private Limited (since 2023) and Director at Anantaa Gsk Ijbelectric Private Limited (since 2022). The companies operate in Healthcare and Plastics. The 2 current companies with reported revenue have a combined latest revenue of ₹1.88 Cr; the largest is Reinvent Medical Private Limited at ₹1.03 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2023 | 2017 | ₹1.03 Cr (FY 2025) | Active | |
| Director | 10 Nov 2022 | 2022 | ₹85.1 Lakh (FY 2024) | Active |
Board colleagues of Sarfroz
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhagwat | 10159134 | Reinvent Medical Private Limited | Additional Director |
| Rakesh Sharma | 09786160 | Anantaa Gsk Ijbelectric Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarfroz
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarfroz
Sarfroz currently holds 2 directorships: Reinvent Medical Private Limited (Director, since 01 Dec 2023, revenue ₹1.03 Cr (FY 2025)); Anantaa Gsk Ijbelectric Private Limited (Director, since 10 Nov 2022, revenue ₹85.1 Lakh (FY 2024)).
Sarfroz was first appointed on 10 Nov 2022 as Director at Anantaa Gsk Ijbelectric Private Limited. The most recent appointment on record is 01 Dec 2023 at Reinvent Medical Private Limited.
The 2 current companies of Sarfroz that report revenue have a combined latest revenue of ₹1.88 Cr: Reinvent Medical Private Limited ₹1.03 Cr (FY 2025); Anantaa Gsk Ijbelectric Private Limited ₹85.1 Lakh (FY 2024).
The current boards of Sarfroz's companies include Bhagwat (Reinvent Medical Private Limited), Rakesh Sharma (Anantaa Gsk Ijbelectric Private Limited).